B3GAT1 and neoplasm: Similar results were observed between tumor-infiltrating CD57+ lymphocytes and OS in head and neck carcinoma (HNC) (HR = 0.26, 95% CI 0.10 to 0.70, P = 0.007) and non-small cell lung cancer (NSCLC) (HR = 0.47, 95% CI 0.28 to 0.77, P = 0.003).